Resultados de la búsqueda
Fayad ZA, Mani V, Woodward M, Kallend D, Bansilal S, Pozza J, Burgess T, Fuster V, Rudd JH, Tawakol A, Farkouh ME. Rationale and design of dal-PLAQUE: a study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomography. Am Heart J (2011) 162:214-221.e2
Sanz G, Fuster V, Guzmán L, Guglietta A, Arnáiz JA, Martínez F, Sarria A, Roncaglioni MC, Taubert K. The Fixed-dose Combination Drug for Secondary Cardiovascular Prevention project: Improving equitable access and adherence to secondary cardiovascular prevention with a fixed-dose combination drug. Study design and objectives. Am Heart J (2011) 162:811-817.e1
Garcia-Alvarez A, Fernandez-Friera L, Lau JF, Sawit ST, Mirelis JG, Castillo JG, Pinney S, Anyanwu AC, Fuster V, Sanz J, Garcia MJ. Evaluation of right ventricular function and post-operative findings using cardiac computed tomography in patients with left ventricular assist devices. J Heart Lung Transplant (2011) 30:896-903
Fernandez-Friera L, Garcia-Alvarez A, Guzman G, Bagheriannejad-Esfahani F, Malick W, Nair A, Fuster V, Garcia MJ, Sanz J. Apical right ventricular dysfunction in patients with pulmonary hypertension demonstrated with magnetic resonance. Heart (2011) 97:1250-6
Moreno PR, Astudillo L, Elmariah S, Purushothaman KR, Purushothaman M, Lento PA, Sharma SK, Fuster V, Adams DH. Increased macrophage infiltration and neovascularization in congenital bicuspid aortic valve stenosis. J Thorac Cardiov Sur (2011) 42:895-901
Fernandez-Friera L, Garcia-Alvarez A, Bagheriannejad-Esfahani F, Malick W, Mirelis JG, Sawit ST, Fuster V, Sanz J, Garcia MJ, Hermann LK. Diagnostic value of coronary artery calcium scoring in low-intermediate risk patients evaluated in the emergency department for acute coronary syndrome. Am J Cardiol (2011) 107:17-23
Falk E, Sillesen H, Muntendam P, Fuster V. The High-Risk Plaque Initiative: Primary Prevention of Atherothrombotic Events in the Asymptomatic Population. Curr Atheroscler Rep (2011) 13:359-66
Fuster V, Sanz G. [Fixed-dose compounds and the secondary prevention of ischemic heart disease] Rev Esp Cardiol (2011) 64:3-9
Franco M, Cooper R, Bilal U, Fuster V. Control of Coronary Heart Disease Risk Factors and Evidence-Based Therapies: Joint Efforts for Coronary Heart Disease Prevention in Spain. Rev Esp Cardiol (2011) 64:962-4
Sanz G, Fuster V. Polypill and global cardiovascular health strategies. Semin Thorac Cardiovasc Surg. (2011) 21:24-9
